Shaddy Robert E, George Aneesh Thomas, Jaecklin Thomas, Lochlainn Eimear Nic, Thakur Lalit, Agrawal Rumjhum, Solar-Yohay Susan, Chen Fabian, Rossano Joseph W, Severin Thomas, Burch Michael
Children's Hospital Los Angeles, 4650 Sunset Blvd. MS#126, Los Angeles, CA, 90027, USA.
Novartis Healthcare Pvt. Ltd., Hyderabad, India.
Pediatr Cardiol. 2018 Mar;39(3):415-436. doi: 10.1007/s00246-017-1787-2. Epub 2017 Dec 20.
While the epidemiology of adult heart failure has been extensively researched, this systematic review addresses the less well characterized incidence and prevalence of pediatric HF. The search strategy used Cochrane methodology and identified 83 unique studies for inclusion. Studies were categorized according to whether the HF diagnosis was reported as primary (n = 10); associated with other cardiovascular diseases (CVDs) (n = 49); or associated with non-CVDs (n = 24). A narrative synthesis of the evidence is presented. For primary HF, the incidence ranged from 0.87/100,000 (UK and Ireland) to 7.4/100,000 (Taiwan). A prevalence of 83.3/100,000 was reported in one large population-based study from Spain. HF etiology varied across regions with lower respiratory tract infections and severe anemia predominating in lower income countries, and cardiomyopathies and congenital heart disease major causes in higher income countries. Key findings for the other categories included a prevalence of HF associated with cardiomyopathies ranging from 36.1% (Japan) to 79% (US); associated with congenital heart disease from 8% (Norway) to 82.2% (Nigeria); associated with rheumatic heart diseases from 1.5% (Turkey) to 74% (Zimbabwe); associated with renal disorders from 3.8% (India) to 24.1% (Nigeria); and associated with HIV from 1% (US) to 29.3% (Brazil). To our knowledge, this is the first systematic review of the topic and strengthens current knowledge of pediatric HF epidemiology. Although a large body of research was identified, heterogeneity in study design and diagnostic criteria limited the ability to compare regional data. Standardized definitions of pediatric HF are required to facilitate cross-regional comparisons of epidemiological data.
虽然成人心力衰竭的流行病学已得到广泛研究,但本系统评价关注的是儿童心力衰竭特征描述较少的发病率和患病率。检索策略采用Cochrane方法,共识别出83项纳入研究。研究根据心力衰竭诊断报告为原发性(n = 10)、与其他心血管疾病(CVD)相关(n = 49)或与非心血管疾病相关(n = 24)进行分类。对证据进行了叙述性综合分析。对于原发性心力衰竭,发病率范围从0.87/100,000(英国和爱尔兰)到7.4/100,000(台湾)。西班牙一项大型基于人群的研究报告患病率为83.3/100,000。心力衰竭病因因地区而异,低收入国家以下呼吸道感染和严重贫血为主,而高收入国家心肌病和先天性心脏病是主要病因。其他类别研究的主要发现包括:与心肌病相关的心力衰竭患病率从36.1%(日本)到79%(美国);与先天性心脏病相关的从8%(挪威)到82.2%(尼日利亚);与风湿性心脏病相关的从1.5%(土耳其)到74%(津巴布韦);与肾脏疾病相关的从3.8%(印度)到24.1%(尼日利亚);与HIV相关的从1%(美国)到29.3%(巴西)。据我们所知,这是该主题的首次系统评价,加强了当前对儿童心力衰竭流行病学的认识。尽管识别出大量研究,但研究设计和诊断标准的异质性限制了比较区域数据的能力。需要标准化的儿童心力衰竭定义以促进流行病学数据的跨区域比较。